Miniatura

Fitxers

695043.pdf (2.89 MB)

Tipus de document

Article

Versió

Versió publicada

Data de publicació

2019-10-29

Llicència de publicació

cc by (c) Menchón Magriñá, José Manuel et al., 2019
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/176452

A prospective international multi-center study on safety and efficacy of deep brain stimulation for resistant obsessive-compulsive disorder

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

https://doi.org/10.1038/s41380-019-0562-6

Resum

Deep brain stimulation (DBS) has been proposed for severe, chronic, treatment-refractory obsessive-compulsive disorder (OCD) patients. Although serious adverse events can occur, only a few studies report on the safety profile of DBS for psychiatric disorders. In a prospective, open-label, interventional multi-center study, we examined the safety and efficacy of electrical stimulation in 30 patients with DBS electrodes bilaterally implanted in the anterior limb of the internal capsule. Safety, efficacy, and functionality assessments were performed at 3, 6, and 12 months post implant. An independent Clinical Events Committee classified and coded all adverse events (AEs) according to EN ISO14155:2011. All patients experienced AEs (195 in total), with the majority of these being mild (52% of all AEs) or moderate (37%). Median time to resolution was 22 days for all AEs and the etiology with the highest AE incidence was 'programming/stimulation' (in 26 patients), followed by 'New illness, injury, condition' (13 patients) and 'pre-existing condition, worsening or exacerbation' (11 patients). Sixteen patients reported a total of 36 serious AEs (eight of them in one single patient), mainly transient anxiety and affective symptoms worsening (20 SAEs). Regarding efficacy measures, Y-BOCS reduction was 42% at 12 months and the responder rate was 60%. Improvements in GAF, CGI, and EuroQol-5D index scores were also observed. In sum, although some severe AEs occurred, most AEs were mild or moderate, transient and related to programming/stimulation and tended to resolve by adjustment of stimulation. In a severely treatment-resistant population, this open-label study supports that the potential benefits outweigh the potential risks of DBS.

Matèries

Neurosi obsessiva, Estimulació del cervell, Seguretat dels pacients

Matèries (anglès)

Obsessive-compulsive disorder, Brain stimulation, Patients safety

Citació

Col·leccions

Articles publicats en revistes (Ciències Clíniques)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Citació

MENCHÓN MAGRIÑÁ, José manuel, REAL, Eva, ALONSO, Pino, APARICIO, Marco alberto, SEGALÀS COSI, Cinto, PLANS, Gerard, LUYTEN, Laura, BRUNFAUT, Els, MATTHIJS, Laurean, RAYMAKERS, Simon, BERVOETS, Chris, HIGUERAS, Antonio, KATATI, Majed, GUERRERO, José, HURTADO, Mariena, PRIETO, Mercedes, STIEGLITZ, Lennart h., LÖFFELHOLZ, Georg, WALTHER, Sebastian, POLLO, Claudio, ZUROWSKI, Bartosz, TRONNIER, Volker, KORDON, Andreas, GAMBINI, Orsola, RANIERI, Rebecca, FRANZINI, Angelo, MESSINA, Giuseppe, RADU DJURFELDT, Diana, SCHECHTMANN, Gaston, CHEN, Long-long, EITAN, Renata, ISRAEL, Zvi, BERGMAN, Hagai, BRELJE, Tim, BRIONNE, Thomas c., CONSEIL, Aurélie, GIELEN, Frans, SCHUEPBACH, Michael, NUTTIN, Bart, GABRIËLS, Loes. A prospective international multi-center study on safety and efficacy of deep brain stimulation for resistant obsessive-compulsive disorder. _Molecular Psychiatry_. 2019. Vol. 26, núm. 1234-1247. [consulta: 10 de gener de 2026]. ISSN: 1359-4184. [Disponible a: https://hdl.handle.net/2445/176452]

Exportar metadades

JSON - METS

Compartir registre